title: Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.
abstract: Human plasminogen activator inhibitor type 1 (PAI-1) is a serine protease inhibitor with a metastable active conformation. Under physiological conditions, half of the inhibitor transitions to a latent state within 1-2 h. The interaction between PAI-1 and the plasma protein vitronectin prolongs this active lifespan by ∼50%. Previously, our group demonstrated that PAI-1 binds to resins using immobilized metal affinity chromatography (Day, U.S. Pat. 7,015,021 B2, March 21, 2006). In this study, the effect of these metals on function and stability was investigated by measuring the rate of the transition from the active to latent conformation. All metals tested showed effects on stability, with the majority falling into one of two types depending on their effects. The first type of metal, which includes magnesium, calcium and manganese, invoked a slight stabilization of the active conformation of PAI-1. A second category of metals, including cobalt, nickel and copper, showed the opposite effects and a unique vitronectin-dependent modulation of PAI-1 stability. This second group of metals significantly destabilized PAI-1, although the addition of vitronectin in conjunction with these metals resulted in a marked stabilization and slower conversion to the latent conformation. In the presence of copper and vitronectin, the half-life of active PAI-1 was extended to 3 h, compared to a half-life of only ∼30 min with copper alone. Nickel had the largest effect, reducing the half-life to ∼5 min. Together, these data demonstrate a heretofore-unknown role for metals in modulating PAI-1 stability.
authors.affiliation: Department of Biochemistry and Cellular and Molecular Biology, University of Tennessee, Knoxville, Tennessee 37996, USA.
authors.forename: Lawrence C
authors.initials: LC
authors.lastname: Thompson
authors.forename: Sumit
authors.initials: S
authors.lastname: Goswami
authors.forename: David S
authors.initials: DS
authors.lastname: Ginsberg
authors.forename: Duane E
authors.initials: DE
authors.lastname: Day
authors.forename: Ingrid M
authors.initials: IM
authors.lastname: Verhamme
authors.forename: Cynthia B
authors.initials: CB
authors.lastname: Peterson
mesh_terms: D001665:Binding Sites; D002118:Calcium / Q000737:chemistry / Q000378:metabolism*; D002712:Chlorides / Q000737:chemistry / Q000378:metabolism; D002846:Chromatography, Affinity; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D007700:Kinetics; D008274:Magnesium / Q000737:chemistry / Q000378:metabolism*; D019216:Metals, Heavy / Q000737:chemistry / Q000378:metabolism*; D017395:Plasminogen Activator Inhibitor 1 / Q000737:chemistry* / Q000378:metabolism*; D055550:Protein Stability; D013002:Somatomedins / Q000737:chemistry / Q000378:metabolism; D019096:Vitronectin / Q000737:chemistry / Q000378:metabolism
chemical_list: D002712:Chlorides; D019216:Metals, Heavy; D017395:Plasminogen Activator Inhibitor 1; C051321:SERPINE1 protein, human; D013002:Somatomedins; D019096:Vitronectin; C016756:somatomedin B; D008274:Magnesium; D002118:Calcium